Alpha GPC (L‑alpha‑glycerylphosphorylcholine) is a highly bioavailable choline donor used for brain and performance support. Clinical data in mild cognitive impairment (MCI) and dementia are promising; small sports studies suggest modest power/strength effects. Typical evidence‑based intakes are 300–600 mg pre‑workout or 600–1,200 mg/day for cognition. Safety is generally good short‑term, but a large cohort linked long‑term α‑GPC use to higher stroke risk, so long-term, high-dose use warrants caution and medical guidance. However, a 2025 Korean study (n>2M) found reduced stroke risk in MCI patients using it preventively.
Featured Snippet (What it is, 40–58 words):
Alpha GPC (L‑alpha‑glycerylphosphorylcholine) is a choline‑rich compound that crosses into the brain and supplies choline for acetylcholine and phospholipid synthesis. It delivers ~40% choline by weight and has been used in clinical trials at 600–1,200 mg/day for cognitive support and 300–600 mg around exercise.
Alpha GPC is structurally a glycerophosphocholine that provides choline—an essential nutrient involved in neurotransmission and membrane integrity. Compared with other choline sources, Alpha GPC contains a higher percentage of choline and readily raises circulating choline.
After oral intake, Alpha GPC is hydrolyzed to choline and glycerophosphate. Choline is used to synthesize acetylcholine (ACh) and phosphatidylcholine. Peak plasma choline typically occurs ~3–4 hours after a 1,200 mg dose, informing timing for cognitive tasks and training.
Mechanistically, Alpha GPC:
Evidence grades: A = strong, B = promising, C = preliminary/mixed.
For acute performance or demanding cognitive tasks, take Alpha GPC 60–120 minutes beforehand. This bridges the gap between common pre‑exercise protocols (≈90 min) and pharmacokinetic data showing peak plasma choline around 3–4 hours after dosing. For daily cognitive support, morning or split AM/PM dosing is reasonable.
Cognition (MCI/dementia):
Athletic performance:
Acute endocrine effects:
Short‑term Alpha GPC helps some people with MCI and may give a small edge for power/strength. It’s not a cure‑all, and athletic effects are modest. For chronic, high‑dose use, weigh benefits against potential stroke risk signal from a large cohort study.
Typical tolerance: In clinical use up to 1,200 mg/day for months, Alpha GPC is generally well tolerated; reported side effects include GI upset, headache, insomnia, agitation, hypotension, usually mild/transient.
Potential cardiovascular signal: A nationwide Korean 10‑year cohort (12 million adults ≥50 y) associated α‑GPC prescriptions with a ~46% higher incident stroke risk, dose‑responsive, though a 2025 study showed reduced risk in MCI non-converters. Causality isn’t proven; residual confounding is possible, and some reviews have questioned the analysis. Nonetheless, this warrants caution with long‑term, high‑dose use.
Mechanistic concern: Preclinical work suggests Alpha GPC can be metabolized to TMAO, a pro‑atherogenic metabolite, and promoted atherosclerosis in hyperlipidemic mice—supporting biological plausibility for a vascular signal. Human causality remains unconfirmed.
Drug interactions & who should avoid:
This article is informational and not medical advice. Consult a qualified clinician for personal dosing or if you take prescription medicines.
In MCI, a 12‑week RCT (600 mg/day) improved ADAS‑Cog versus placebo. In dementia, a 2023 meta‑analysis suggests benefits (alone or with donepezil). Data in healthy adults are limited.
Most positive trials used 250–600 mg daily for pre‑workout; take it 60–120 min before training. Expect modest effects on power/strength, not dramatic changes.
Alpha GPC delivers more choline by weight than citicoline and raises choline efficiently; both cross the BBB and can support acetylcholine synthesis. Choice often depends on response and tolerance.
Short‑term intakes up to 1,200 mg/day are generally well tolerated, but a large cohort linked long‑term α‑GPC use with higher stroke risk. Use the lowest effective dose, monitor total choline, and speak with your clinician if considering chronic use.
For acute focus (presentations, exams), take 60–120 minutes before the task to align with rising plasma choline; for ongoing cognitive goals, morning or split AM/PM dosing is reasonable.
Evidence compares Alpha GPC to caffeine rather than combining them; synergy is unproven. If you combine, start low to assess tolerance (e.g., jitteriness).
One small poster study reported higher GH when 600 mg was taken ~90 min before exercise. These are preliminary findings that need replication.
Track diet, multivitamins, and supplements. The adult UL for choline is 3.5 g/day; Alpha GPC contributes ~0.4 mg choline per 1 mg. Stay comfortably below the UL and avoid stacking multiple high‑choline products.